A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified February 2013 by GL Pharm Tech Corporation
Sponsor:
Information provided by (Responsible Party):
GL Pharm Tech Corporation
ClinicalTrials.gov Identifier:
NCT01779492
First received: January 28, 2013
Last updated: February 18, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: May 2013
  Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)